Haohai Biotech announced that on August 31, 2026, the company repurchased 35,600 H shares through the Hong Kong Stock Exchange. The repurchase price range for each share was HK$16.29 to HK$16.58, with a total cost of HK$586,900. All of the shares repurchased will be cancelled. The repurchase is based on the repurchase authorization passed by the shareholders' meeting on May 29, 2026. The total number of shares that can be repurchased under this authorization is 3.478 million shares. Up to now, 610,000 shares have been repurchased, accounting for 1.75% of the shares issued on the date the authorization was approved.

Haohai Biotech announced that on August 31, 2026, the company repurchased 35,600 H shares through the Hong Kong Stock Exchange. The repurchase price range for each share was HK$16.29 to HK$16.58, with a total cost of HK$586,900. All of the shares repurchased will be cancelled. The repurchase is based on the repurchase authorization passed by the shareholders' meeting on May 29, 2026. The total number of shares that can be repurchased under this authorization is 3.478 million shares. Up to now, 610,000 shares have been repurchased, accounting for 1.75% of the shares issued on the date the authorization was approved.